BETHESDA, Md.--()--Wondering how many top life sciences CEOs got where they are today? The 2012 Mid-Atlantic Bio Conference, taking place September 27-28 at the Bethesda Marriott, will give attendees the inside track on how area biotech CEOs found their way to the top during a panel on building value and planning exits.
“I expect attendees will be engaged – and entertained – as we hear from the leaders in our field, particularly as they share the twists and turns involved in their rise to the top.”
In addition, CEOs from the area’s top hospital centers will provide insight into the delivery of healthcare services today. Are today’s hospitals willing to buy new technology? How can today’s hospital system be successful? Conference attendees will have a unique opportunity to speak to the executives at the top of Adventist Healthcare and Inova Health System.
Acorda Therapeutics’s top exec will also provide insight into the life sciences industry during a panel on what’s next for the industry. During the panel, experts from the FDA and New Enterprise Associates will also weigh in on the future of biotech, investment and public policy.
“The CEOs participating on our panels promise to provide Mid-Atlantic Bio attendees with terrific insights into our evolving healthcare delivery system, as well as a rapidly-changing life sciences sector,” said Jeffrey M. Gallagher, Virginia Bio Interim Executive Director. “I expect attendees will be engaged – and entertained – as we hear from the leaders in our field, particularly as they share the twists and turns involved in their rise to the top.”
DAY ONE: Capstone Plenary Panel: The Business of Health Delivery from Leaders of Today’s Hospital Systems
This keynote panel focuses on the challenges faced by health care providers as they transition from the current fee-for-service sick-care system to be successful in the outcomes-focused budgeted system of the future. Panelists will discuss how this transition will impact healthcare technology providers.
Moderator: Bruce Robertson, Ph.D., Managing Director, HIG
William G. “Bill” Robertson, President and CEO, Adventist Healthcare
Knox Singleton, CEO, Inova Health System
DAY ONE: Plenary Panel: Seeing a Bright Future: What’s ahead for an ever-changing Life Sciences Industry
Thought leaders from industry, investment and public policy share observations and insights on developments, trends and opportunities.
Moderator: Steve Usdin, Senior Editor, BioCentury
M. James Barrett, Ph.D., General Partner, New Enterprise Associates (NEA)
Vicki Seyfert-Margolis, Ph.D., Senior Advisor to Chief Scientist, FDA
Ron Cohen, M.D., President and CEO Acorda Therapeutics, Inc.
DAY TWO: CEO Roundtable: Building Value and Planning Exits - Lessons Learned
There are many paths to building enterprise value and many roads to an eventual exit event. Seasoned CEOs from different sectors of the life sciences and companies at different stages along the way tell their stories – dead ends, hairpin turns, boulevards and super highways, and share their insights.
Moderator: Brad L. Stewart, Chairman, CEO and President,
Cynthia Collins, President and CEO, GenVec, Inc.
Ken Carter, Ph.D., President and CEO, Neximmune, Inc and Chairman, Nobel Life Sciences, Inc.
About Mid-Atlantic Bio
Mid-Atlantic Bio – taking place September 27-28 in Bethesda, Md. – is one of the country’s premier biotech conferences for senior-level executives, policymakers, academia, financiers, media and service providers. Its proximity to the US government, federal labs, commercial research and development, academic centers of excellence and a growing investment community, make it a uniquely valuable venue for those in the life sciences community. First launched as an industry gathering at the Academies of Science, the conference is a joint initiative of the founding host organizations: the Mid-Atlantic Venture Association, the Virginia Biotechnology Association, and the Tech Council of Maryland. The Conference is also pleased to welcome the North Carolina Biotechnology Center as strategic partner for 2012. For more information, please visit midatlanticbio.org.